WATCH THE REPLAY
Webinar: Optimizing your pre-launch activities to impact time to peak sales
The commercialization process for a new drug is long, complex and expensive. For biopharma companies, bringing a drug to market typically takes 10-15 years and can require more than $2 billion dollars. With this level of investment, it’s generally important to look across each phase of commercialization and identify areas of optimization to maximize the timeline to peak sales. That said, the most successful organizations ensure they’ve built a strong foundation in the early phases of commercialization so they can start the journey on the ‘right foot’.
In this 30-minute session, Robert Groebel, VP of Global Life Sciences Strategy at Definitive Healthcare will lead a discussion on how to optimize the key pre-launch activities which can positively impact your timeline to peak sales. Join live to learn:
- How to select the fastest recruiting trial sites and investigators
- Strategies to remove data silos across clinical and commercial teams
- Ways to engage KOLs to identify scientific and competitive intelligence
About the speaker
Robert Groebel, VP, Global Medical Strategy
Robert Groebel is the Global VP of Medical Strategy at Definitive Healthcare. He is recognized for his ability to create a strategic vision and accelerate innovation via technology. Most recently, he was the Global Vice President, Medical & Account Management Strategy at Veeva Systems. He has more than 25 years of healthcare experience holding global medical and commercial roles at both Boehringer Ingelheim and Shire Pharmaceuticals. In his current role, he guides commercial & medical affairs organizations globally to leverage technology, data, and analytics to enhance engagement, scientific, communications, and account management strategies in today’s increasingly complex healthcare landscape.
Watch on demand
Get a sneak peek into the webinar! Read a preview of the transcript below:
Jamie Friscino (00:00):
All right. I think we might have everyone here. All right, everyone. Welcome to today’s webinar. My name is Jamie Friscino. I am a senior product marketing manager here at Definitive Healthcare. Welcome to today’s session, optimizing your pre-launch activities to impact time to peak sales. I’m joined today by my colleague, Robert Groebel, who is the VP of global medical strategy. Robert has over 25 years of experience in the healthcare industry and joins us from places like Viva Systems, Boehringer Ingelheim, and Schneider Pharmaceuticals. Personally, I’ve been fortunate enough to join Robert on several client-facing calls over the last couple of months and am continually impressed by his depth of expertise and ability to translate his experience into actionable intelligence for our clients. So I’m really excited that he’s been able to package all this wealth of knowledge up and be able to share that out with everyone on the line today.
Jamie Friscino (00:48):
But before I turn it over to Robert, just want to quickly mention that while we are only live for 25 to 30 minutes here, we do want to try to leave time at the end to address any questions that you may have. So please submit those via the chat function throughout Robert’s presentation. And if we can’t get to them live at the end of the session today, we’ll be sure to respond to you offline to get you the answer to your question. And with that, I’d like to turn it over to Robert to introduce himself and take it away. Robert?
Robert Groebel (01:12):
Thanks, Jamie. I appreciate the kind introduction. I hope you haven’t overpromised. Before we start, let me just give you a little background on Definitive Healthcare. We’re an organization that’s about 10 years old now. We’ve been working across the healthcare industry where we are bringing multiple sources of data together, both unstructured and structured data, that we then work with this data to develop holistic healthcare intelligence, whether it’s applying data science to it, cleansing the data or linking the data together. It allows us to bring these data products and these data insights to our clients by linking these things together to provide comprehensive and proprietary intelligence covering the entire healthcare ecosystem, not just pharma, where we’ll focus today. But it’s a really interesting organization. And I think when I think about all of the clients that we’re working with, we’re helping them to really supercharge their both in-market activities as well as their pre-commercial activities.
Robert Groebel (02:19):
And as we start the webinar today, I want to frame the discussion over the next 20 or 25 minutes around the challenges that we’re seeing today as it relates to bringing products to market with therapies for the patients that need them. And as Jamie said, I’ve been in the industry for about 25 years now. And when I started on the commercial side of pharma, we were working with population health drugs. They were large markets, easily understood interventions, but many of us now are focused in rare disease, perhaps cell and gene therapy. And there are a host of new challenges that we’re facing both medically and commercially to really effectively bring these therapies to market in the most timely manner possible… .